Phenotypic analysis of extracellular vesicles:a review on the applications of fluorescence

Extracellular vesicles (EVs) have numerous potential applications in the field of healthcare and diagnostics, and research into their biological functions is rapidly increasing. Mainly because of their small size and heterogeneity, there are significant challenges associated with their analysis and despite overt evidence of the potential of EVs in clinical diagnostic practice, guidelines for analytical procedures have not yet been properly established. Here, we present an overview of the main methods for studying the properties of EVs based on the principles of fluorescence. Setting aside the isolation, purification and physicochemical characterization strategies which answer questions about the size, surface charge and stability of EVs (reviewed elsewhere), we focus on available optical tools that enable the direct analysis of phenotype and mechanisms of interaction with tissues. In brief, the topics on which we elaborate range from the most popular approaches such as nanoparticle tracking analysis and flow cytometry, to less commonly used techniques such as fluorescence depolarization and microarrays as well as emerging areas such as fast fluorescence lifetime imaging microscopy (FLIM). We highlight that understanding the strengths and limitations of each method is essential for choosing the most appropriate combination of analytical tools. Finally, future directions of this rapidly developing area of medical diagnostics are discussed

Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries.

The prognosis of children with neuroblastoma (NBL) can be dismal with significant variations depending on the stage and biology of the tumor. We assessed the event-free (EFS) and overall (OS) survival using harmonized data from three Southern-Eastern European (SEE) countries. Data for 520 incident NBL cases (2009-2018) were collected from Greece, Slovenia and Russia. Kaplan-Meier curves were fitted, and EFS/OS were derived from Cox proportional models by study variables including the protocol-based risk-group (low/observation, intermediate, high). Over one-third of cases were coded in the high-risk group, of which 23 children (4.4%) received treatment with anti-ganglioside 2 (GD2) mAb. Survival rates were inferior in older (OS 5-year; 1.5-4.9 years: 61%; EFS 5-year; 1.5-4.9 years: 48%) compared to children younger than 1.5 years (OS 5-year; <1.5 years: 91%; EFS 5-year; <1.5 years: 78%). Predictors of poor OS included stage 4 (hazard ratio, HROS: 18.12, 95% confidence intervals, CI: 3.47-94.54), N-myc amplification (HROS: 2.16, 95% CI: 1.40-3.34), no surgical excision (HROS: 3.27, 95% CI: 1.91-5.61) and relapse/progression (HROS: 5.46, 95% CI: 3.23-9.24). Similar unfavorable EFS was found for the same subsets of patients. By contrast, treatment with anti-GD2 antibody in high-risk patients was associated with decreased risk of death or unfavorable events (HROS: 0.11, 95% CI: 0.02-0.79; HREFS: 0.19, 95% CI: 0.07-0.52). Our results confirm the outstanding prognosis of the early NBL stages, especially in children <1.5 years, and the improved outcomes of the anti-GD2 treatment in high-risk patients. Ongoing high-quality clinical cancer registration is needed to ensure comparability of survival across Europe and refine our understanding of the NBL biology

Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure A Prospective, Randomized Study

Objectives The purpose of this study was to test the efficacy of a 6-month course of anti-inflammatory treatment with colchicine in improving functional status of patients with stable chronic heart failure (CHF). Background CHF has been shown to be associated with inflammatory activation. Inflammation has been designated as a therapeutic target in CHF. Methods Patients with stable CHF were randomly assigned to colchicine (0.5 mg twice daily) or placebo for 6 months. The primary endpoint was the proportion of patients achieving at least one-grade improvement in New York Heart Association class. Results Two hundred sixty-seven patients were available for final evaluation of the primary endpoint: its rate was 11% in the control group and 14% in the colchicine group (odds ratio: 1.40; 95% confidence interval: 0.67 to 2.93; p = 0.365). The rate of the composite of death or hospital stay for heart failure was 9.4% in the control group, compared with 10.1% in the colchicine group (p = 0.839). The changes in treadmill exercise time with treatment were insignificant and similar in the 2 groups (p = 0.938). C-reactive protein and interleukin-6 were both significantly reduced in the colchicine group (-5.1 mg/l and -4.8 pg/ml, respectively; p < 0.001 for both, compared with the control group). Conclusions According to this prospective, randomized study, anti-inflammatory treatment with colchicine in patients with stable CHF, although effective in reducing inflammation biomarker levels, did not affect in any significant way patient functional status (in terms of New York Heart Association class and objective treadmill exercise tolerance) or the likelihood of death or hospital stay for heart failure. (C) 2014 by the American College of Cardiology Foundatio

Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium.

BackgroundParental age has been associated with several childhood cancers, albeit the evidence is still inconsistent.AimTo examine the associations of parental age at birth with acute myeloid leukemia (AML) among children aged 0-14 years using individual-level data from the Childhood Leukemia International Consortium (CLIC) and non-CLIC studies.Material/methodsWe analyzed data of 3182 incident AML cases and 8377 controls from 17 studies [seven registry-based case-control (RCC) studies and ten questionnaire-based case-control (QCC) studies]. AML risk in association with parental age was calculated using multiple logistic regression, meta-analyses, and pooled-effect estimates. Models were stratified by age at diagnosis (infants <1 year-old vs. children 1-14 years-old) and by study design, using five-year parental age increments and controlling for sex, ethnicity, birthweight, prematurity, multiple gestation, birth order, maternal smoking and education, age at diagnosis (cases aged 1-14 years), and recruitment time period.ResultsAdjusted odds ratios (ORs) and 95% confidence intervals (CIs) derived from RCC, but not from the QCC, studies showed a higher AML risk for infants of mothers ≥40-year-old (OR = 6.87; 95% CI: 2.12-22.25). There were no associations observed between any other maternal or paternal age group and AML risk for children older than one year.ConclusionsAn increased risk of infant AML with advanced maternal age was found using data from RCC, but not from QCC studies; no parental age-AML associations were observed for older children

Parental age and the risk of childhood acute myeloid leukemia: results from the Childhood Leukemia International Consortium.

BackgroundParental age has been associated with several childhood cancers, albeit the evidence is still inconsistent.AimTo examine the associations of parental age at birth with acute myeloid leukemia (AML) among children aged 0-14 years using individual-level data from the Childhood Leukemia International Consortium (CLIC) and non-CLIC studies.Material/methodsWe analyzed data of 3182 incident AML cases and 8377 controls from 17 studies [seven registry-based case-control (RCC) studies and ten questionnaire-based case-control (QCC) studies]. AML risk in association with parental age was calculated using multiple logistic regression, meta-analyses, and pooled-effect estimates. Models were stratified by age at diagnosis (infants <1 year-old vs. children 1-14 years-old) and by study design, using five-year parental age increments and controlling for sex, ethnicity, birthweight, prematurity, multiple gestation, birth order, maternal smoking and education, age at diagnosis (cases aged 1-14 years), and recruitment time period.ResultsAdjusted odds ratios (ORs) and 95% confidence intervals (CIs) derived from RCC, but not from the QCC, studies showed a higher AML risk for infants of mothers ≥40-year-old (OR = 6.87; 95% CI: 2.12-22.25). There were no associations observed between any other maternal or paternal age group and AML risk for children older than one year.ConclusionsAn increased risk of infant AML with advanced maternal age was found using data from RCC, but not from QCC studies; no parental age-AML associations were observed for older children

Dynamics of hydration water in gelatin and hyaluronic acid hydrogels

[EN] We employed broadband dielectric spectroscopy (BDS), for the investigation of the water dynamics in partially hydrated hyaluronic acid (HA), and gelatin (Gel), enzymatically crosslinked hydrogels, in the water fraction ranges [Formula: see text]. Our results indicate that at low hydrations ([Formula: see text]), where the dielectric response of the hydrogels is identical during cooling and heating, water plasticizes strongly the polymeric matrix and is organized in clusters giving rise to [Formula: see text]-process, secondary water relaxation and to an additional slower relaxation process. This later process has been found to be related with the dc charge conductivity and can be described in terms of the conduction current relaxation mechanism. At slightly higher hydrations, however, always below the hydration level where ice is formed during cooling, we have recorded in HA hydrogel a strong water dielectric relaxation process, [Formula: see text], which has Arrhenius-like temperature dependence and large time scale resembling relaxation processes recorded in bulk low density amorphous solid water structures. This relaxation process shows a strong-to-fragile transition at [Formula: see text]C and our data suggest that the VTF-like process recorded at [Formula: see text]C is controlled by the same molecular process like long range charge transport. In addition, our data imply that the crossover temperature is related with the onset of structural rearrangements (increase in configurational entropy) of the macromolecules. In partially crystallized hydrogels ([Formula: see text]) HA exhibits at low temperatures the ice dielectric process consistent with the bulk hexagonal ice, whereas Gel hydrogel exhibits as main low temperature process a slow relaxation process that refers to open tetrahedral structures of water similar to low density amorphous ice structures and to bulk cubic ice. Regarding the water secondary relaxation processes, we have shown that the [Formula: see text]-process and the [Formula: see text] process are activated in water hydrogen bond networks with different structures.The support from Ministerio de Economia, Industria y Competitividad (MINECO) through the MAT2016-76039-C4-1-R project (including the FEDER funds) is acknowledged. The CIBER-BBN initiative is funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program. CIBER actions are financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. We thank Dr. P. Klonos for his assistance in preparing scheme 1.Kripotou, S.; Zafeiris, K.; Culebras-Martinez, M.; Ferrer, G.; Kyritsis, A. (2019). Dynamics of hydration water in gelatin and hyaluronic acid hydrogels. The European Physical Journal E. 42(8):1-18. https://doi.org/10.1140/epje/i2019-11871-2S118428M. Heyden, J. Chem. Phys. 141, 22D509 (2014)D. Laage, T. Elsaesser, J.T. Hynes, Chem. Rev. 117, 10694 (2017)R. Biswas, B. Bagchi, J. Phys.: Condens. Matter 30, 013001 (2018)A.S. Hoffman, Adv. Drug Deliv. Rev. 43, 3 (2002)B.V. Slaughter, S.S. Khurshid, O.Z. Fisher, A. Khademhosseini, N.A. Peppas, Adv. Mater. 21, 3307 (2009)S. Khodadadi, A.P. Sokolov, Soft Matter 11, 4984 (2015)S. Cerveny, I. Combarro-Palacios, J. Swenson, Phys. Chem. Lett. 7, 4093 (2016)F. Mallamace, C. Corsaro, P. Baglioni, E. Fratini, S.-H. Chen, J. Phys.: Condens. Matter 24, 064103 (2012)P.W. Fenimore et al., Chem. Phys. 424, 2 (2013)W.G. Liu, K.D. Yao, Polymer 42, 3943 (2001)E. Mamontov, Y. Yue, J. Bahadur, J. Guo, C.I. Contescu, N.C. Gallego, Y.B. Melnichenko, Carbon 111, 705 (2017)J. Swenson, Phys. Chem. Chem. Phys. 20, 30095 (2018)J.L. Finney, Philos. Trans. R. Soc. Lond. B 359, 1145 (2004)P.G. Debenedetti, J. Phys.: Condens. Matter 15, R1669 (2003)M. Kobayashi, H. Tanaka, J. Phys. Chem. B 115, 14077 (2011)G. Bullock, V. Molinero, Faraday Discuss. 167, 371 (2013)K. Amann-Winkel, R. Böhmer, C. Gainaru, F. Fujara, B. Geil, T. Loerting, Rev. Mod. Phys. 88, 011002 (2016)N. Kastelowitz, V. Molinero, ACS Nano 12, 8234 (2018)U. Kaatze, J. Mol. Liq. 162, 105 (2011)G. Franzese, V. Bianco, S. Iskrov, Food Biophys. 6, 186 (2011)M.D. Fayer, Acc. Chem. Res. 45, 3 (2012)D. Russo, J. Teixeira, J. Non-Cryst. Solids 407, 459 (2015)L. Zhao, K. Ma, Z. Yang, Int. J. Mol. Sci. 16, 8454 (2015)I. Brovchenko, A. Oleinikova, Chem. Phys. Chem. 9, 2695 (2008)M. Rosenstihl, K. Kämpf, F. Klameth, M. Sattig, M. Vogel, J. Non-Cryst. Solids 407, 449 (2015)J. Wolfe, G. Bryant, K.L. Koster, CryoLetters 23, 157 (2002)L. Lupi, A. Hudait, V. Molinero, J. Am. Chem. Soc. 136, 3156 (2014)P. Gallo et al., Chem. Rev. 116, 7463 (2016)O. Mishima, H.E. Stanley, Nature 396, 329 (1998)H.E. Stanley et al., J. Non-Cryst. Solids 357, 629 (2011)F. Bruni, R. Mancinelli, M.A. Ricci, J. Mol. Liq. 176, 39 (2012)F. Caupin, J. Non-Cryst. Solids 407, 441 (2015)N. Shinyashiki, M. Shimomura, T. Ushiyama, T. Miyagawa, S. Yagihara, J. Phys. Chem. B 111, 10079 (2007)S. Gekle, R.R. Netz, J. Chem. Phys. 137, 104704 (2012)P. Ben Ishai, S.R. Tripathi, K. Kawase, A. Puzenko, Y. Feldman, Phys. Chem. Chem. Phys. 17, 15428 (2015)U. Kaatze, J. Chem. Phys. 147, 024502 (2017)D.R. Martin, J.E. Forsmo, D.V. Matyushov, J. Phys. Chem. B 122, 3418 (2018)D.E. Stillman, J.A. MacGregor, R.E. Grimm, J. Geophys. Res. 118, 1 (2013)I. Popov, A. Puzenko, A. Khamzin, Y. Feldman, Phys. Chem. Chem. Phys. 17, 1489 (2015)K. Sasaki, R. Kita, N. Shinyashiki, S. Yagihara, J. Phys. Chem. B 120, 3950 (2016)T. Yasuda, K. Sasaki, R. Kita, N. Shinyashiki, S. Yagihara, J. Phys. Chem. B 121, 2896 (2017)P. Pissis, A. Kyritsis, J. Polym. Sci. Part B: Polym. Phys. 51, 159 (2013)J. Swenson, S. Cerveny, J. Phys.: Condens. Matter 27, 033102 (2015)S. Cerveny, F. Mallamace, J. Swenson, M. Vogel, L. Xu, Chem. Rev. 116, 7608 (2016)N. Shinyashiki, S. Sudo, S. Yagihara, A. Spanoudaki, A. Kyritsis, P. Pissis, J. Phys. C: Condens. Matter 19, 205113 (2007)S. Capaccioli, K.L. Ngai, N. Shinyashiki, J. Phys. Chem. B 111, 8197 (2007)S. Cerveny, Á. Alegría, J. Colmenero, Phys. Rev. E 77, 031803 (2008)C. Gainaru, A. Fillmer, R. Böhmer, J. Phys. Chem. B 113, 12628 (2009)A. Kyritsis, A. Panagopoulou, P. Pissis, R.S.i. Serra, J.L. Gomez Ribelles, N. Shinyashiki, IEEE Trans. Dielectr. Electr. Insul. 19, 1239 (2012)A. Panagopoulou, A. Kyritsis, N. Shinyashiki, P. Pissis, J. Phys. Chem. B 116, 4593 (2012)A. Panagopoulou, A. Kyritsis, M. Vodina, P. Pissis, Biochim. Biophys. Acta 1834, 977 (2013)K.L. Ngai, S. Capaccioli, S. Ancherbak, N. Shinyashiki, Philos. Mag. 91, 1809 (2011)K.L. Ngai, S. Capaccioli, A. Paciaroni, Biochim. Biophys. Acta 1861, 3553 (2017)S. Cerveny, G.A. Schwartz, R. Bergman, J. Swenson, Phys. Rev. Lett. 93, 245702 (2004)J. Swenson, J. Phys.: Condens. Matter 16, S5317 (2004)S. Capaccioli, K.L. Ngai, S. Ancherbak, P.A. Rolla, N. Shinyashiki, J. Non-Cryst. Solids 357, 641 (2011)S. Capaccioli, K.L. Ngai, J. Chem. Phys. 135, 104504 (2011)J.E. Scott, F. Heatley, Biomacromolecules 3, 547 (2002)C. Alber, J. Engblom, P. Falkman, V. Kocherbitov, J. Phys. Chem. B 119, 4211 (2015)T. Hatakeyama, M. Tanaka, A. Kishi, H. Hatakeyama, Thermochim. Acta 532, 159 (2012)A. Pruŝová, F.J. Vergeldt, J. Kucerík, Carbohydr. Polym. 95, 515 (2013)S. Kawabe, M. Seki, H. Tabata, J. Appl. Phys. 115, 125 (2014)O. Miyawaki, C. Omote, K. Matsuhira, Biopolymers 103, 685 (2015)S. Thakur, P.P. Govender, M.A. Mamo, S. Tamulevicius, K. Kumar, V. Thakur, Vacuum 146, 396 (2017)A. Panagopoulou, J. Vázquez Molina, A. Kyritsis, M. Monleón Pradas, A. Valles Lluch, G. Gallego Ferrer, P. Pissis, Food Biophys. 8, 192 (2013)K. Sasaki, R. Kita, N. Shinyashiki, S. Yagihara, J. Chem. Phys. 140, 124506 (2014)K. Sasaki, A. Panagopoulou, R. Kita, N. Shinyashiki, S. Yagihara, A. Kyritsis, P. Pissis, J. Phys. Chem. B 121, 265 (2017)S. Poveda-Reyes, V. Moulisova, E. Sanmartín-Masiá, L. Quintanilla-Sierra, M. Salmerón-Sánchez, G. Gallego Ferrer, Macromol. Biosci. 16, 1311 (2016)V. Moulisova, S. Poveda-Reyes, E. Sanmartín-Masiá, L. Quintanilla-Sierra, M. Salmerón-Sánchez, G. Gallego Ferrer, ACS Omega 2, 7609 (2017)E. Sanmartín-Masiá, S. Poveda-Reyes, G. Gallego Ferrer, Int. J. Polym. Mater. Polym. Biomater. 66, 280 (2017)L. Greenspan, J. Res. Natl. Bur. Stand. A Phys. Chem. 81A, 89 (1977)F. Kremer, A. Schönhals, Broadband Dielectric Spectroscopy (Springer, Berlin, 2002)M. Wübbenhorst, J. van Turnhout, J. Non-Cryst. Solids 305, 40 (2002)R. Pelster, A. Kops, G. Nimtz, A. Enders, H. Kietzmann, P. Pissis, A. Kyritsis, D. Woermann, Ber. Bunsenges. Phys. Chem. 97, 666 (1993)K. Pathmanathan, G.P. Johari, J. Chem. Soc., Faraday Trans. 90, 1143 (1994)Y. Suzuki, M. Steinhart, R. Graf, H.-J. Butt, G. Floudas, J. Phys. Chem. B 119, 14814 (2015)G.P. Johari, E. Whalley, J. Chem. Phys. 75, 1333 (1981)P.M. Suherman, P. Taylor, G. Smith, J. Non-Cryst. Solids 305, 317 (2002)K.-D. Kreuer, Chem. Mater. 8, 610 (1996)M.G. Mazza et al., Proc. Natl. Acad. Sci. U.S.A. 108, 19873 (2011)E. Brini, C.J. Fennell, M. Fernandez-Serra, B. Hribar-Lee, M. Luksic, K.A. Dill, Chem. Rev. 117, 12385 (2017)O. Andersson, J. Phys.: Condens. Matter 20, 244115 (2008)C. Gainaru et al., Proc. Natl. Acad. Sci. U.S.A. 111, 17402 (2014)G.P. Johari, O. Andersson, Thermochim. Acta 461, 14 (2007)E.B. Moore, E. de la Lave, K. Welke, D.A. Scherlis, V. Molinero, Phys. Chem. Chem. Phys. 12, 4124 (2010)N. Shinyashiki et al., J. Phys. Chem. B 113, 14448 (2009)E.B. Moore, J.T. Allen, V. Molinero, J. Phys. Chem. C 116, 7507 (2012)S.R. Gough, D.W. Davidson, J. Chem. Phys. 52, 5442 (1970)T. Loerting et al., J. Non-Cryst. Solids 407, 423 (2015)K. Yamamoto, H. Namikawa, Jpn. J. Appl. Phys. 27, 1845 (1988)K. Yamamoto, H. Namikawa, Jpn. J. Appl. Phys. 28, 2523 (1989)P. Pissis, A. Kyritsis, V.V. Shilov, Solid State Ion. 125, 203 (1999)J.C. Dyre, T.B. Schrøder, Rev. Mod. Phys. 72, 873 (2000)J.C. Dyre, P. Maass, B. Roling, D.L. Sidebottom, Rep. Prog. Phys. 72, 046501 (2009)C. Gainaru et al., J. Phys. Chem. B 120, 11074 (2016)M. Nakanishi, A.P. Sokolov, J. Non-Cryst. Solids 407, 478 (2015